Abstract
Agar and broth microdilution MICs of Ro 23-9424 that inhibited 90% of 22 Legionella clinical isolates tested were 0.64 and 0.08 micrograms/ml, respectively; respective erythromycin values were 1.0 and 0.12 micrograms/ml. Ro 23-9424 (1 microgram/ml) was slightly more active than the same erythromycin concentration in a macrophage system, for both Legionella pneumophila strains studied.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beskid G., Fallat V., Lipschitz E. R., McGarry D. H., Cleeland R., Chan K., Keith D. D., Unowsky J. In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents. Antimicrob Agents Chemother. 1989 Jul;33(7):1072–1077. doi: 10.1128/aac.33.7.1072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Christenson J. G., Chan K. K., Cleeland R., Dix-Holzknecht B., Farrish H. H., Jr, Patel I. H., Specian A. Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals. Antimicrob Agents Chemother. 1990 Oct;34(10):1895–1900. doi: 10.1128/aac.34.10.1895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edelstein P. H., Edelstein M. A., Holzknecht B. In vitro activities of fleroxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia. Antimicrob Agents Chemother. 1992 Nov;36(11):2387–2391. doi: 10.1128/aac.36.11.2387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edelstein P. H., Edelstein M. A. WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages. Antimicrob Agents Chemother. 1989 Dec;33(12):2132–2136. doi: 10.1128/aac.33.12.2132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edelstein P. H., Edelstein M. A., Weidenfeld J., Dorr M. B. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia. Antimicrob Agents Chemother. 1990 Nov;34(11):2122–2127. doi: 10.1128/aac.34.11.2122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Georgopapadakou N. H., Bertasso A., Chan K. K., Chapman J. S., Cleeland R., Cummings L. M., Dix B. A., Keith D. D. Mode of action of the dual-action cephalosporin Ro 23-9424. Antimicrob Agents Chemother. 1989 Jul;33(7):1067–1071. doi: 10.1128/aac.33.7.1067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gu J. W., Neu H. C. In vitro activity of Ro 23-9424, a dual-action cephalosporin, compared with activities of other antibiotics. Antimicrob Agents Chemother. 1990 Feb;34(2):189–195. doi: 10.1128/aac.34.2.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones R. N., Barry A. L. Antimicrobial activity of imipenem and SCH34343 against Legionella species. Diagn Microbiol Infect Dis. 1987 Apr;6(4):307–309. doi: 10.1016/0732-8893(87)90180-5. [DOI] [PubMed] [Google Scholar]
- Liebers D. M., Baltch A. L., Smith R. P., Hammer M. C., Conroy J. V. Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions. J Antimicrob Chemother. 1989 Jan;23(1):37–41. doi: 10.1093/jac/23.1.37. [DOI] [PubMed] [Google Scholar]
- Ruckdeschel G., Ehret W., Ahl A. Susceptibility of Legionella spp. to imipenem and 27 other beta-lactam antibiotics. Eur J Clin Microbiol. 1984 Oct;3(5):463–467. doi: 10.1007/BF02017376. [DOI] [PubMed] [Google Scholar]
- Toro J., Sawatari K., Kanda T., Saito A., Hara K. New beta-lactamase-resistant cephem treatment of guinea pigs infected with Legionella pneumophila. Microbiol Immunol. 1983;27(8):649–654. doi: 10.1111/j.1348-0421.1983.tb00627.x. [DOI] [PubMed] [Google Scholar]
- Yoshida S., Mizuguchi Y. Antibiotic susceptibility of Legionella pneumophia Philadelphia-1 in cultured guinea-pig peritoneal macrophages. J Gen Microbiol. 1984 Apr;130(4):901–906. doi: 10.1099/00221287-130-4-901. [DOI] [PubMed] [Google Scholar]